Literature DB >> 24280975

A grounded explanation of why women present with advanced breast cancer.

Nur Aishah Taib1, Cheng Har Yip, Wah Yun Low.   

Abstract

BACKGROUND: Advanced breast cancer presentation remains a large obstacle in lowering mortality rates in low- and middle-resource countries. This study aims to explore the reasons why women present with breast cancer at an advanced stage.
METHODS: Purposive sampling of 19 breast cancer patients presenting with advanced cancer that were diagnosed within 2 years at the University Malaya Medical Centre, Kuala Lumpur, Malaysia. In-depth interviews were conducted, and audio-recordings were transcribed. Sample size was determined by theoretic sufficiency, and the constructivist grounded theory method was used.
RESULTS: The reasons for delayed presentation can be displayed in two models. The total breast cancer delay (TBCD) model was derived from the journey of the patients. Four concepts emerged: (1) pluralistic health systems; (2) points of delay; (3) presence of patient or system delays, and (4) patient decision-making at each stage. Eight points of delay were found. At each point, evidence of a patient decision-making model emerged: the breast cancer delay explanatory (BCDE) model, which was the process of assessing severity and knowing and choosing options. The four main operational constructs were (1) knowledge on disease and disease outcomes, (2) knowledge of treatment and treatment outcomes, (3) psychological and physical resources and support; and (4) roles in decision-making.
CONCLUSIONS: The phenomenon is explained by the TBCD and BCDE models. Deconstructing why women present with advanced breast cancer and resist treatment provides clarity of the issues and opportunities for intervention.

Entities:  

Mesh:

Year:  2014        PMID: 24280975     DOI: 10.1007/s00268-013-2339-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model.

Authors:  C Charles; A Gafni; T Whelan
Journal:  Soc Sci Med       Date:  1999-09       Impact factor: 4.634

2.  Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.

Authors:  Caroline Dancyger; Jonathan A Smith; Chris Jacobs; Melissa Wallace; Susan Michie
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 3.  Crisis decision theory: decisions in the face of negative events.

Authors:  Kate Sweeney
Journal:  Psychol Bull       Date:  2008-01       Impact factor: 17.737

4.  The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection.

Authors:  Noreen C Facione; Christine Miaskowski; Marylin J Dodd; Steven M Paul
Journal:  Prev Med       Date:  2002-04       Impact factor: 4.018

5.  The Ottawa patient decision aids.

Authors:  A M O'Connor; E R Drake; V Fiset; I D Graham; A Laupacis; P Tugwell
Journal:  Eff Clin Pract       Date:  1999 Jul-Aug

6.  Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women--the psycho-socio-cultural model for breast symptom appraisal: opportunities for intervention.

Authors:  Nur Aishah Taib; Cheng-Har Yip; Wah-Yun Low
Journal:  Asian Pac J Cancer Prev       Date:  2011

7.  Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients.

Authors:  Garth H Rauscher; Carol Estwing Ferrans; Karen Kaiser; Richard T Campbell; Elizabeth E Calhoun; Richard B Warnecke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

8.  Breast cancer delay: a grounded model of help-seeking behaviour.

Authors:  Karla Unger-Saldaña; Claudia B Infante-Castañeda
Journal:  Soc Sci Med       Date:  2011-02-18       Impact factor: 4.634

9.  Decision making during serious illness: what role do patients really want to play?

Authors:  L F Degner; J A Sloan
Journal:  J Clin Epidemiol       Date:  1992-09       Impact factor: 6.437

10.  Social and cultural meanings of self-efficacy.

Authors:  Nancy J Burke; Joyce A Bird; Melissa A Clark; William Rakowski; Claudia Guerra; Judith C Barker; Rena J Pasick
Journal:  Health Educ Behav       Date:  2009-10
View more
  16 in total

1.  Recognizing pitfalls in breast cancer follow-up: a necessity--reply.

Authors:  Nur Aishah Taib
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

2.  Recognizing pitfalls in breast cancer follow-up: a necessity.

Authors:  Behnam Dalfardi
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

3.  "Alas … my sickness becomes my family's burden": A nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia.

Authors:  Yayi Suryo Prabandari; Wika Hartanti; Mentari Widiastuti; Riani Witaningrum; Susanna Hilda Hutajulu; Matthew John Allsop
Journal:  Breast       Date:  2022-04-04       Impact factor: 4.254

4.  Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.

Authors:  Yew-Ching Teh; Gie-Hooi Tan; Nur Aishah Taib; Kartini Rahmat; Caroline Judy Westerhout; Farhana Fadzli; Mee-Hoong See; Suniza Jamaris; Cheng-Har Yip
Journal:  BMC Cancer       Date:  2015-05-15       Impact factor: 4.430

5.  Barriers to early presentation of self-discovered breast cancer in Singapore and Malaysia: a qualitative multicentre study.

Authors:  Jennifer N W Lim; Barbara Potrata; Leonardo Simonella; Celene W Q Ng; Tar-Ching Aw; Maznah Dahlui; Mikael Hartman; Rifhan Mazlan; Nur Aishah Taib
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

6.  Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.

Authors:  Noor Mastura Mohd Mujar; Maznah Dahlui; Nor Aina Emran; Imisairi Abdul Hadi; Yan Yang Wai; Sarojah Arulanantham; Chea Chan Hooi; Nur Aishah Mohd Taib
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Non-communicable Disease Surveillance in Malaysia: An Overview of Existing Systems and Priorities Going Forward.

Authors:  Arunah Chandran; Shurendar Selva Kumar; Noran Naqiah Hairi; Wah Yun Low; Feisul Idzwan Mustapha
Journal:  Front Public Health       Date:  2021-07-06

8.  The Malaysian Breast Cancer Survivorship Cohort (MyBCC): a study protocol.

Authors:  Tania Islam; Nirmala Bhoo-Pathy; Tin Tin Su; Hazreen Abdul Majid; Azmi Mohd Nahar; Chong Guan Ng; Maznah Dahlui; Samsinah Hussain; Marie Cantwell; Liam Murray; Nur Aishah Taib
Journal:  BMJ Open       Date:  2015-10-26       Impact factor: 2.692

9.  Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women.

Authors:  Shamsiah Abdul Hamid; Kartini Rahmat; Marlina Tanty Ramli; Farhana Fadzli; Suniza Jamaris; Mee Hoong See; Kean Hooi Teoh; Nur Aishah Mohd Taib
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

10.  Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study.

Authors:  Aina Farhana Zulkipli; Tania Islam; Nur Aishah Mohd Taib; Maznah Dahlui; Nirmala Bhoo-Pathy; Nabilla Al-Sadat; Hazreen Abdul Majid; Samsinah Hussain
Journal:  Integr Cancer Ther       Date:  2017-12-08       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.